Thor Medical ASA
TRMED · Oslo Børs · Healthcare
4.50NOK
+1.0%last day
Price as of 2 October 2026
Performance
1 month
−17.7%
1 year
+37.6%
3 years, per year
+47.7%
5 years, per year
−27.8%
Largest fall, 3 years
−97.1%
Below the peak now
−96.2%
Volatility, 1 year
63.3%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
4.1
Dividend yield
0.0%
Return on equity
−6.9%
Net margin
–
Market value
168 m USD
Quality, value and trend
Where Thor Medical stands against every Nordic stock today. 100 is best.
20
Profitability and a sound balance sheet over time. Better than 20% of Nordic stocks.
9
The price measured against earnings, assets and cash flow. Better than 9% of Nordic stocks.
68
The price development over the past year. Better than 68% of Nordic stocks.
17
Quality, value and trend together. Better than 17% of Nordic stocks.
About Thor Medical
Thor Medical ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 24 employees.
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis